Table 1.
Participant characteristics at baseline.
Table 2.
Participant characteristics at follow-up fibrosis assessment.
Fig 1.
A. Fibrosis staging of HCV cohort at baseline and follow-up. B. Sustained virological response is associated with stable / improved liver fibrosis. C. Persistent HCV is associated with liver fibrosis progression.
Table 3.
Predictors of liver fibrosis progression—Failure to attain SVR and longer duration of infection prior to HCV treatment.